Rocket Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: RCKT
Share price (11/13/26): $2.30
Market cap (11/13/26): $257 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 425 95 pages Agreement and Plan of Merger by and Among Rocket Pharmaceuticals, Inc., Zebrafish Merger Sub, Inc., Zebrafish Merger Sub II, LLC, and Renovacor, Inc. Dated as of September 19, 2022

from 8-K 95 pages Agreement and Plan of Merger by and Among Rocket Pharmaceuticals, Inc., Zebrafish Merger Sub, Inc., Zebrafish Merger Sub II, LLC, and Renovacor, Inc. Dated as of September 19, 2022

from 8-K 116 pages Agreement and Plan of Merger and Reorganization Among: Inotek Pharmaceuticals Corporation, a Delaware Corporation; Rome Merger Sub, a Cayman Islands Exempted Company; and Rocket Pharmaceuticals, Ltd., a Cayman Islands Exempted Company Dated as of September 12, 2017

from DEFA14A 116 pages Agreement and Plan of Merger and Reorganization Among: Inotek Pharmaceuticals Corporation, a Delaware Corporation; Rome Merger Sub, a Cayman Islands Exempted Company; and Rocket Pharmaceuticals, Ltd., a Cayman Islands Exempted Company Dated as of September 12, 2017

from SC 13G 2 pages Joint Filing Agreement

from SC 13D 5 pages Plan of reorganization, merger, acquisition or similar